PKAAX
Price
$14.10
Change
+$0.10 (+0.71%)
Updated
Sep 4 closing price
Net Assets
1.39B
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

PKAAX vs VIVIX

Header iconPKAAX vs VIVIX Comparison
Open Charts PKAAX vs VIVIXBanner chart's image
PIMCO RAE US A
Price$14.10
Change+$0.10 (+0.71%)
VolumeN/A
Net Assets1.39B
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
PKAAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PKAAX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. PKAAX (1.4B). VIVIX pays higher dividends than PKAAX: VIVIX (2.11) vs PKAAX (1.41). PKAAX was incepted earlier than VIVIX: PKAAX (10 years) vs VIVIX (27 years). PKAAX (0.81) is less costly to investors than VIVIX (0.04). PKAAX is a more actively managed with annual turnover of: 73.00 vs. VIVIX (9.00). PKAAX has a lower initial minimum investment than VIVIX: PKAAX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. PKAAX (3.29). VIVIX return over 5 years is better than : 70.16 vs. PKAAX (49.88).
PKAAXVIVIXPKAAX / VIVIX
Total Expense Ratio0.800.042,000%
Annual Report Gross Expense Ratio0.810.042,025%
Fund Existence10 years27 years-
Gain YTD11.5937.866147%
Front Load4%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B203B1%
Annual Yield % from dividends1.412.1167%
Returns for 1 year3.297.7443%
Returns for 3 years25.0036.6168%
Returns for 5 years49.8870.1671%
Returns for 10 years80.69131.6161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia